000 00993 a2200289 4500
005 20250513160401.0
264 0 _c19981204
008 199812s 0 0 eng d
022 _a0028-4793
040 _aNLM
_beng
_cNLM
100 1 _aNathan, D G
245 0 0 _aIron chelation with oral deferiprone in patients with thalassemia.
_h[electronic resource]
260 _bThe New England journal of medicine
_cDec 1998
300 _a1711-2; author reply 1713-4 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aBiopsy
650 0 4 _aDeferiprone
650 0 4 _aHumans
650 0 4 _aIron Chelating Agents
_xadverse effects
650 0 4 _aIron Overload
_xdrug therapy
650 0 4 _aLiver
_xpathology
650 0 4 _aLiver Cirrhosis
_xetiology
650 0 4 _aPyridones
_xadverse effects
650 0 4 _abeta-Thalassemia
_xpathology
700 1 _aWeatherall, D J
773 0 _tThe New England journal of medicine
_gvol. 339
_gno. 23
_gp. 1711-2; author reply 1713-4
999 _c9830298
_d9830298